性行為感染傳染病診斷檢測市場（按檢測類型和地區）

Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, and Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

出版日期: 2025年06月20日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

性行為感染傳染病診斷檢測市場規模預計在 2025 年達到 124.9 億美元，預計到 2032 年將達到 237.3 億美元，2025 年至 2032 年的複合年成長率為 9.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	124.9億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年	9.60%	2032年價值預測	237.3億美元

性行為感染傳染病 (STD) 是透過性接觸在人與人之間傳播的疾病。及早發現和診斷性傳染病可以防止進一步感染。實驗室檢查可以透過血液檢查、尿液檢體、腰椎穿刺和體液檢體確定病因並發現合併感染疾病。對無症狀族群進行疾病檢測稱為篩檢。篩檢可以針對多種感染疾病進行，包括愛滋病毒、B型肝炎、披衣菌感染、梅毒、淋病和C型肝炎。性行為感染的治療方法是使用抗生素和抗病毒藥物，以防止疾病進一步傳播。

市場動態

性行為感染）的盛行率不斷上升，政府對性行為感染治療和管理的投入預計將推動全球性行為感染診斷檢測市場的成長。例如，2023年2月2日，印度生物技術公司Mylab Discovery Solutions Pvt. Ltd.推出了針對性傳播感染（性行為感染）的快速檢測套組，包括人類免疫力缺乏病毒（HIV）、C型肝炎病毒（HCV）和梅毒。在這些檢測中，HIV 1/2 Ab和HCV Ab是分別檢測HIV-1、HIV-2和HCV特異性抗體的快速檢測，而梅毒抗體檢測則是檢測有助於診斷梅毒的抗體（IgG、IgA和IgM）。

研究的主要特點

本報告對全球性行為感染診斷檢測市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模（十億美元）和年複合成長率（CAGR）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球性行為感染傳染病診斷測試市場的主要企業概況。
研究涉及的主要企業包括 Vela Diagnostics USA Inc.、Roche Holdings AG、Alere, Inc.、Becton Dickinson & Company、bioMerieux、Danaher Corporation (Beckman Coulter)、Hologic, Inc.、binx health、Chembio Diagnostics、Pinpoint Science Inc. 和 bioLytical Laboratories。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球性行為感染診斷測試市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過全球性行為感染診斷測試市場分析中使用的各種策略矩陣來促進決策。

介紹
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 北非
- 中部非洲
- 南非

第6章競爭態勢

Vela Diagnostics USA Inc.
Roche Holdings AG
Alere, Inc.
Becton Dickinson & Company
bioMerieux
Danaher Corporation（Beckman Coulter）
Hologic, Inc.
binx health
Chembio Diagnostics
Pinpoint Science Inc.
bioLytical Laboratories

第 7 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI3917

Diagnostic Testing Of Stds Market is estimated to be valued at USD 12.49 Bn in 2025 and is expected to reach USD 23.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 12.49 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.60%	2032 Value Projection:	USD 23.73 Bn

Sexually Transmitted Diseases (STDs) are diseases that spread from person-to-person through sexual contact. Early identification or diagnosis of STDs can help stop further transmission. Laboratory tests can identify the cause and detect co-infections through blood tests, urine samples, swab tests, lumbar puncture, and fluids samples. Testing for a disease in someone who doesn't have symptoms is called screening. The screening can be done for a variety of infections like HIV, hepatitis B, chlamydia, syphilis, gonorrhea, and hepatitis C. Cervical cancer is often caused by certain strains of HPV. Treatment of STDs can be done by antibiotics and antiviral drugs which prevents the further spread of disease.

Market Dynamics

The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.

Key features of the study

This report provides an in-depth analysis of the global diagnostic testing of STDs market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global diagnostic testing of STDs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics.
The global diagnostic testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic testing of STDs market.

Market Segmentation

Global Diagnostic Testing of STDs Market, By Test Type
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
Global Diagnostic Testing of STDs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- Vela Diagnostics USA Inc.
- Roche Holdings AG
- Alere, Inc.
- Becton Dickinson & Company
- bioMerieux
- Danaher Corporation (Beckman Coulter)
- Hologic, Inc.
- binx health
- Chembio Diagnostics
- Pinpoint Science Inc.
- bioLytical Laboratories.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Diagnostic Testing of STDs Market, By Test Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Chlamydia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gonorrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HPV+ pap smear
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chancroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Diagnostic Testing of STDs Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

6. Competitive Landscape

Vela Diagnostics USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Roche Holdings AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alere, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton Dickinson & Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Danaher Corporation (Beckman Coulter)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
binx health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chembio Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pinpoint Science Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioLytical Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies